148 related articles for article (PubMed ID: 25954348)
1. Semantic processing to identify adverse drug event information from black box warnings.
Culbertson A; Fiszman M; Shin D; Rindflesch TC
AMIA Annu Symp Proc; 2014; 2014():442-8. PubMed ID: 25954348
[TBL] [Abstract][Full Text] [Related]
2. Semantic processing to identify adverse drug event information from black box warnings.
Culbertson A; Fiszman M; Shin D; Rindflesch TC
AMIA Annu Symp Proc; 2013; 2013():266. PubMed ID: 24551335
[TBL] [Abstract][Full Text] [Related]
3. Medicare Prescription Drug Plan Formulary Restrictions After Postmarket FDA Black Box Warnings.
Solotke MT; Ross JS; Shah ND; Karaca-Mandic P; Dhruva SS
J Manag Care Spec Pharm; 2019 Nov; 25(11):1201-1217. PubMed ID: 31663461
[TBL] [Abstract][Full Text] [Related]
4. Ethical and Practical Considerations in Removing Black Box Warnings from Drug Labels.
Yeh JS; Sarpatwari A; Kesselheim AS
Drug Saf; 2016 Aug; 39(8):709-14. PubMed ID: 27000800
[TBL] [Abstract][Full Text] [Related]
5. US Food and Drug Administration Black Box Warnings.
Smith RG
J Am Podiatr Med Assoc; 2020 Jan; 110(1):Article10. PubMed ID: 32073327
[TBL] [Abstract][Full Text] [Related]
6. Era of faster FDA drug approval has also seen increased black-box warnings and market withdrawals.
Frank C; Himmelstein DU; Woolhandler S; Bor DH; Wolfe SM; Heymann O; Zallman L; Lasser KE
Health Aff (Millwood); 2014 Aug; 33(8):1453-9. PubMed ID: 25092848
[TBL] [Abstract][Full Text] [Related]
7. Adverse Event extraction from Structured Product Labels using the Event-based Text-mining of Health Electronic Records (ETHER) system.
Pandey A; Kreimeyer K; Foster M; Dang O; Ly T; Wang W; Forshee R; Botsis T
Health Informatics J; 2019 Dec; 25(4):1232-1243. PubMed ID: 29359620
[TBL] [Abstract][Full Text] [Related]
8. Extraction Of Adverse Events From Clinical Documents To Support Decision Making Using Semantic Preprocessing.
Gaebel J; Kolter T; Arlt F; Denecke K
Stud Health Technol Inform; 2015; 216():1030. PubMed ID: 26262330
[TBL] [Abstract][Full Text] [Related]
9. Drug knowledge expressed as computable semantic triples.
Elkin PL; Carter JS; Nabar M; Tuttle M; Lincoln M; Brown SH
Stud Health Technol Inform; 2011; 166():38-47. PubMed ID: 21685609
[TBL] [Abstract][Full Text] [Related]
10. FDA boxed warnings: how to prescribe drugs safely.
O'Connor NR
Am Fam Physician; 2010 Feb; 81(3):298-303. PubMed ID: 20112888
[TBL] [Abstract][Full Text] [Related]
11. Risk management policy and black-box warnings: a qualitative analysis of US FDA proceedings.
Cook DM; Gurugubelli RK; Bero LA
Drug Saf; 2009; 32(11):1057-66. PubMed ID: 19810777
[TBL] [Abstract][Full Text] [Related]
12. Mining FDA drug labels using an unsupervised learning technique--topic modeling.
Bisgin H; Liu Z; Fang H; Xu X; Tong W
BMC Bioinformatics; 2011 Oct; 12 Suppl 10(Suppl 10):S11. PubMed ID: 22166012
[TBL] [Abstract][Full Text] [Related]
13. Timing of new black box warnings and withdrawals for prescription medications.
Lasser KE; Allen PD; Woolhandler SJ; Himmelstein DU; Wolfe SM; Bor DH
JAMA; 2002 May; 287(17):2215-20. PubMed ID: 11980521
[TBL] [Abstract][Full Text] [Related]
14. Building a knowledge base of severe adverse drug events based on AERS reporting data using semantic web technologies.
Jiang G; Wang L; Liu H; Solbrig HR; Chute CG
Stud Health Technol Inform; 2013; 192():496-500. PubMed ID: 23920604
[TBL] [Abstract][Full Text] [Related]
15. Mining FDA drug labels for medical conditions.
Li Q; Deleger L; Lingren T; Zhai H; Kaiser M; Stoutenborough L; Jegga AG; Cohen KB; Solti I
BMC Med Inform Decis Mak; 2013 Apr; 13():53. PubMed ID: 23617267
[TBL] [Abstract][Full Text] [Related]
16. Speaking the same language? International variations in the safety information accompanying top-selling prescription drugs.
Kesselheim AS; Franklin JM; Avorn J; Duke JD
BMJ Qual Saf; 2013 Sep; 22(9):727-34. PubMed ID: 23620531
[TBL] [Abstract][Full Text] [Related]
17. The need for contraception in patients taking prescription drugs: a review of FDA warning labels, duration of effects, and mechanisms of action.
Zhang Z; Xu L; Zhang Z; Ding H; Rayburn ER; Li H
Expert Opin Drug Saf; 2018 Dec; 17(12):1171-1183. PubMed ID: 30394114
[No Abstract] [Full Text] [Related]
18. A continuing black hole? The FDA boxed warning: an appeal to improve its clinical utility.
Matlock A; Allan N; Wills B; Kang C; Leikin JB
Clin Toxicol (Phila); 2011 Jul; 49(6):443-7. PubMed ID: 21591886
[TBL] [Abstract][Full Text] [Related]
19. The Value of the Black Box Warning in Dermatology.
Winterfield L; Vleugels RA; Park KK
J Drugs Dermatol; 2015 Jul; 14(7):660-6. PubMed ID: 26151780
[TBL] [Abstract][Full Text] [Related]
20. Impact of FDA Actions, DTCA, and Public Information on the Market for Pain Medication.
Bradford WD; Kleit AN
Health Econ; 2015 Jul; 24(7):859-75. PubMed ID: 25059655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
